157
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Pro198Leu polymorphism in the oxidative stress gene, glutathione peroxidase-1, is associated with a gender-specific risk for panic disorder

, , , , &
Pages 201-207 | Received 21 Nov 2014, Accepted 05 Feb 2015, Published online: 13 Mar 2015

References

  • Aburatani H, Hippo Y, Ishida T, Takashima R, Matsuba C, Kodama T, et al. 1997. Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue. Cancer Res 57:2151–2156.
  • American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders.Text revision. 4th ed. Washington, DC: American Psychiatric Press.
  • Andreazza AC, Frey BN, Valvassori SS, Zanotto C, Gomes KM, Comim CM, et al. 2007. DNA damage in rats after treatment with methylphenidate. Prog Neuropsychopharmacol Biol Psychiatry 31:1282–1288.
  • Bandelow B. 1995. Assessing the efficacy of treatments for panic disorder and agoraphobia: II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10:73–81.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265.
  • Berk M, Ng F, Dean O, Dodd S, Bush AI. 2008. Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci 29:346–351.
  • Chen SK, Hsieh WA, Tsai MH, Chen CC, Hong AI, Wei YH, et al. 2003. Age-associated decrease of oxidative repair enzymes, human 8-oxoguanine DNA glycosylases (hOgg1), in human aging. J Radiat Res (Tokyo) 44:31–35.
  • Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. 1999. Excision of oxidatively damaged DNA bases by the human a-hOgg1 protein and the polymorphic ahOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res 27: 4001–4007.
  • Dringen R. 2000. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649–671.
  • Ersoy MA, Selek S, Celik H, Erel O, Kaya MC, Savas HA, Herken H. 2008. Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder. Int J Neurosci 118:1025–1037.
  • Halliwell B. 2006. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658.
  • Hansen RD, Krath BN, Frederiksen K, Tjønneland A, Overvad K, Roswall N, et al. 2009. GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat Res 664:13–19.
  • Hill JW, Evans MK. 2006. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res 34:1620–1632.
  • Hovatta I, Juhila J, Donner J. 2010. Oxidative stress in anxiety and comorbid disorders. Neurosci Res 68:261–275.
  • Hu YJ, Diamond AM. 2003. Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63:3347–3351.
  • Hung RJ, Hall J, Brennan P, Boffetta P. 2005. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162:925–942.
  • Jorgensen A, Broedbaek K, Fink-Jensen A, Knorr U, Greisen Soendergaard M, Henriksen T, et al. 2013a. Increased systemic oxidatively generated DNA and RNA damage in schizophrenia. Psychiatry Res 209:417–423.
  • Jorgensen A, Maigaard K, Wörtwein G, Hageman I, Henriksen T, Weimann A, et al. 2013b. Chronic restraint stress in rats causes sustained increase in urinary corticosterone excretion without affecting cerebral or systemic oxidatively generated DNA/RNA damage. Prog Neuropsychopharmacol Biol Psychiatry 40:30–37.
  • Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimure H, et al. 1998. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 16:3219–3225.
  • Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S. 2002. Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology 46:186–189.
  • Luna L, Rolseth V, Hildrestrand GA, Otterlei M, Dantzer F, Bjørås M, Seeberg E. 2005. Dynamic relocalization of hOGG1 during the cell cycle is disrupted in cells harbouring the hOGG1–326 polymorphic variant. Nucleic Acids Res 33:1813–1824.
  • Matsuzawa D, Hashimoto K, Shimizu E, Fujisaki M, Iyo M. 2005. Functional polymorphism of the glutathione peroxidase 1 gene is associated with personality traits in healthy subjects. Neuropsychobiology 52:68–70.
  • Matsuzawa D, Hashimoto K, Hashimoto T, Shimizu E, Watanabe H, Fujita Y, et al. 2009. Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population. Am J Med Genet Part B 150B:86–94.
  • Ng F, Berk M, Dean O, Bush AI. 2008. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol 11:851–876.
  • Ozdemir O, Selvi Y, Ozkol H, Tuluce Y, Besiroglu L, Aydin A. 2012. Comparison of superoxide dismutase, glutathione peroxidase and adenosine deaminase activities between respiratory and nocturnal subtypes of patients with panic disorder. Neuropsychobiology 66:244–251.
  • Radicella JP, Dherin C, Desmaze C, Fox MS, Boiteux S. 1997. Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 94:8010–8015.
  • Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, et al. 2003. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121:109–122.
  • Ravn-Haren G, Olsen A, Tjønneland A, Dragsted LO, Nexø BA, Wallin H, et al. 2006. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27(4):820–825.
  • Roldan-Arjona T, Wei YF, Carter KC, Klungland A, Anselmino C, Wang RP, et al. 1997. Molecular cloning and functional expression of a human cDNA encoding the antimutator enzyme 8-hydroxyguanine-DNA glycosylase. Proc Natl Acad Sci USA 94:8016–8020.
  • Rusyn I, Asakura S, Pachkowski B, Bradford BU, Denissenko MF, Peters JM, et al. 2004. Expression of base excision repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res 64:1050–1057.
  • Shinkai T, De Luca V, Zai G, Shaikh S, Matsumoto C, Arnold PD, et al. 2004. No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia. Psychiatr Genet 14:177–180.
  • Schweizer U, Brauer AU, Kohrle J, Nitsch R, Savaskan NE. 2004. Selenium and brain function: A poorly recognized liaison. Brain Res Brain Res Rev 45:164–178.
  • Souza RP, Tampakeras M, Basile V, Shinkai T, Rosa DV, Potkin S, et al. 2009. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects. Hum Psychopharmacol 24:676–679.
  • Teyssier JR, Ragot S, Chauvet-Gélinier JC, Trojak B, Bonin B. 2011. Expression of oxidative stress-response genes is not activated in the prefrontal cortex of patients with depressive disorder. Psychiatry Res 186:244–247.
  • Teyssier JR, Chauvet-Gelinier JC, Ragot S, Bonin B. 2012. Up-Regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores. PLoS one 7:e49677.
  • Teyssier JR, Rey R, Ragot S, Chauvet-Gelinier JC, Bonin B. 2013. Correlative gene expression pattern linking RNF123 to cellular stress-senescence genes in patients with depressive disorder: implication of DRD1 in the cerebral cortex. J Affect Disord 151:432–438.
  • Tural U, Fidaner H, Alkın T, Bandelow B. 2002.Assessing the severity of panic disorder and agoraphobia. Validity, reliability and objectivity of the Turkish translation of the panic and agoraphobia scale. J Anxiety Disord 16:331–340.
  • Vieland VJ, Goodman DW, Chapman T, Fyer AJ. 1996. New segregation analysis of panic disorder. Am J Med Genet 67:147–153.
  • Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. 1997. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305–309.
  • Yao JK, Leonard S, Reddy R. 2006. Altered glutathione redox state in schizophrenia. Dis Markers 22:83–93.
  • Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, et al. 2007. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry 68:754–760.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.